Company: ARAI
Filing Date: 2025-03-24
Form Type: S-1/A
Source: 0001641172-25-000350
Chunk: 80

Company: Arrive AI Inc.
Filing Date: 2025-03-24
Form: S-1/A
Chunk 80
---
 CIP                                                                                                        |
| ○ | US Patent #8 (AB4) (Allowed) Serial No 18/078,985 -                                                                         
 Systems, Devices, and/or Methods for Managing Drone Deliveries – 12 claims without CIP                                      |
| ○ | With                                                                                                                        
 2 more (DD5, DD6) US patents pending – 20 more claims                                                                       |
|   | US Claims                                                                                                                   
 are 170 to date from the issued, allowed and pending ten US patents.                                                        |

Additional international patent applications (48 filed) and extensions, based on these patents, are pending in 21 countries and the EU. Six (6) National/non-US Patents have been issued (based on US Patents 2, 4, and 5) and 42 are pending.

Patent portfolio was strengthened December 18, 2023, with the acquisition of AirBox Technologies ($1.15M all-stock transaction), adding Patents 2, 4, 6, and 8.

Continued Progress on the Arrive AI Product Roadmap

In 2024, while continuing to conduct unpaid pilots, we secured our first commercial contract with a specialty pharmaceutical delivery company on the East Coast. This customer has agreed to both utilize our third-generation Access Points (AP3) in their operations and act as a Value-Added Reseller (VAR) for the AP3 to their customers. Initial units were delivered in Q4-2024. Production MaaS support is anticipated to commence in early -2025, followed by recurring MaaS revenue in the first half of 2025. The terms of this agreement are confidential and not available for public disclosure. However, they define the nature of the customer’s operations, specify the work to be performed by both parties (SOW), and outline where our services will be used. They also detail the services Arrive AI must provide and establish initial pricing. All terms are subject to change as both parties gain insight into the actual economics, benefits, and sustainability of this initial engagement. We anticipate renegotiation in 2026, and the customer may cancel the existing or any renegotiated agreement at any time.

Our 2025 prospect pipeline includes assisted living communities and hospital chains that have expressed interest in implementing AP3 to support courier, drone, and robotic delivery systems.Arrive AI does not know if any of the assisted living communities and hospital
chains that expressed interest will enter into agreements with us for our services.

These opportunities are pending contracts and